Literature DB >> 29730366

Maintenance of therapeutic response after 1 year of apremilast combination therapy compared with monotherapy for the treatment of plaque psoriasis: A multicenter, retrospective study.

Arvin Ighani1, Jorge R Georgakopoulos2, Neil H Shear3, Scott Walsh3, Jensen Yeung4.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29730366     DOI: 10.1016/j.jaad.2018.04.043

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  2 in total

1.  Combination Therapy with Apremilast and Biologics for Psoriasis: A Systematic Review.

Authors:  Mette Gyldenløve; Farzad Alinaghi; Claus Zachariae; Lone Skov; Alexander Egeberg
Journal:  Am J Clin Dermatol       Date:  2022-06-23       Impact factor: 6.233

2.  Cost-utility and budget impact analysis of adding-on apremilast to biologic therapy in the treatment of moderate to severe plaque psoriasis, an Iranian payer perspective.

Authors:  Marzieh Zargaran; Fatemeh Soleymani; Saman Ahmad Nasrollahi; Meysam Seyedifar; Mohammad Mehdi Ashrafian Rahaghi
Journal:  Res Pharm Sci       Date:  2021-06-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.